These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
870 related articles for article (PubMed ID: 14713511)
1. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511 [TBL] [Abstract][Full Text] [Related]
2. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors. Kobzar G; Mardla V; Samel N Platelets; 2011; 22(5):338-44. PubMed ID: 21557683 [TBL] [Abstract][Full Text] [Related]
3. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2. Banerjee D; Mazumder S; Sinha AK Blood Coagul Fibrinolysis; 2014 Sep; 25(6):585-91. PubMed ID: 25083729 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of U46619 induced human platelet aggregation by aspirin. Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053 [TBL] [Abstract][Full Text] [Related]
6. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. Correa JA; López-Villodres JA; Asensi R; Espartero JL; Rodríguez-Gutiérez G; De La Cruz JP Br J Nutr; 2009 Apr; 101(8):1157-64. PubMed ID: 18775097 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets. Harmon S; Inkielewicz-Stepniak I; Jones M; Ledwidge M; Santos-Martinez MJ; Medina C; Radomski MW; Gilmer JF J Pharm Pharmacol; 2012 Jan; 64(1):77-89. PubMed ID: 22150675 [TBL] [Abstract][Full Text] [Related]
8. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related]
9. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511 [TBL] [Abstract][Full Text] [Related]
10. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638 [TBL] [Abstract][Full Text] [Related]
11. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005 [TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro. Weber AA; Reimann S; Schrör K Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
14. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide. Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397 [TBL] [Abstract][Full Text] [Related]
15. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood). Violi F; Praticò D; Iuliano L; Balsano F J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906 [TBL] [Abstract][Full Text] [Related]
16. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood. González-Correa JA; Arrebola MM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez de La Cuesta F; De La Cruz JP Platelets; 2005; 16(3-4):171-9. PubMed ID: 16011961 [TBL] [Abstract][Full Text] [Related]
17. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis. Parks WM; Hoak JC; Czervionke RL J Pharmacol Exp Ther; 1981 Nov; 219(2):415-9. PubMed ID: 7026767 [TBL] [Abstract][Full Text] [Related]
18. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis. Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971 [TBL] [Abstract][Full Text] [Related]
19. Phenylbutazone inhibition of equine platelet function. Meyers KM; Lindner C; Katz J; Grant B Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364 [TBL] [Abstract][Full Text] [Related]
20. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]